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Effects of Direct Tabletting Agents on Drug Release
Kinetics and Swelling Behavior of Hydrophilic Matrix
Tablets
Aims: This work focused on the effects of direct tabletting agents (DC-agents) (Microcel PH101®, Cellactose
80®, Ludipress LCE®, Pharmatose DCL11®) and hydroxypropyl-methylcellulose (HPMC) types (Methocel®
K100LV, K15M, K100M) on release of Verapamil HCl from hydrophilic matrix tablets and swelling behaviors
of these tablets.
Material and Methods: Tablets were prepared by direct compression method. In vitro dissolution and
swelling degree tests were performed on the tablets. The release mechanisms of drug were evaluated by using
Korsmeyer-Peppas model.
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Results: While the increase in cellulose content of DC-agents contributed to the swelling of matrices and
decreased the release rate of drug from the matrices, in contrast the increase in lactose content of DC-agents
caused a faster hydration and erosion of the matrices and accelerated the release of drug. The increase in
viscosity grade of HPMC resulted as a decrease in release rate of drug and Methocel K15M and K100M
delayed the release of drug to the same extent. Drug release was mainly fitted to the non-Fickian transport
®
mechanism and became diffusive by decreasing the R/F values of the matrices. Tablets containing Cellactose
80 showed an equal contribution of diffusion and swelling with 3 types of HPMCs, according to their n values
®
and R/F profiles. The FM1 formulation containing Microcel PH101 with Methocel K100LV and the reference
®
product Isoptin -KKH both showed a non-Fickian transport mechanism and they were found to be similar
depending on the values of difference factor (f1 = 9.4) and similarity factor (f2 = 56.8).
Conclusions: An extended release tablet formulation can be prepared as a matrix tablet by using a cellulose
based DC-agent and a low viscosity grade HPMC polymer as an alternative to film coated tablets.
Key Words: Hydroxypropyl-methylcellulose, Direct tabletting agents, Matrix tablet, Swelling degree,
Verapamil hydrochloride

Do¤rudan Tabletleme Ajanlar›n›n Hidrofilik Matris Tabletlerin ﬁiﬂme
Davran›ﬂlar› ve Etkin Madde Sal›m Kinetikleri Üzerindeki Etkileri
®

®

Amaç: Bu çal›ﬂma, farkl› do¤rudan tabletleme ajanlar› (DT-ajanlar›) (Microcel PH101 , Cellactose 80 ,
®
®
®
Ludipress LCE , Pharmatose DCL11 ) ve hidroksipropilmetilselüloz (HPMC) türlerinin (Methocel K100LV,
K15M, K100M) do¤rudan bas›m yöntemi ile haz›rlanan hidrofilik matris tabletlerden Verapamil HCl sal›m› ve
bu tabletlerin ﬂiﬂme davran›ﬂlar› üzerindeki etkilerine odaklanm›ﬂt›r.
Yöntem ve Gereç: Tabletler do¤rudan bas›m yöntemi ile haz›rlanm›ﬂt›r. Tabletlerde in vitro çözünme h›z› ve
ﬂiﬂme de¤eri testleri yap›lm›ﬂt›r. Etkin madde sal›m mekanizmalar› Korsmeyer-Peppas modeli ile
de¤erlendirilmiﬂtir.
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Bulgular: DT-ajanlar›n›n selüloz içeri¤indeki art›ﬂ matrislerin ﬂiﬂmelerine katk›da bulunup matrislerden etkin
madde sal›m h›z›n› düﬂürmekteyken, aksine DT-ajanlar›n›n laktoz içeri¤indeki art›ﬂ matrislerin h›zl›
hidratasyonuna ve erozyonuna neden olarak etkin maddenin sal›m›n› h›zland›rmaktad›r. HPMC`nin
viskozitesindeki art›ﬂ etkin maddenin sal›m h›z›nda azalmaya neden olmakta ve Methocel K15M ve K100M
etkin madde sal›m›n› ayn› derecede geciktirmektedir. Etkin madde sal›m› temel olarak Fick difüzyonuna
uymayan sal›m göstermekte ve matrislerin R/F de¤erindeki azalma ile difüzyon a¤›rl›kl› hale gelmektedir.
®
Cellactose 80 içeren tabletler üç tür HPMC ile, n de¤erleri ve R/F profillerine göre, difüzyon ve ﬂiﬂmenin eﬂit
®
katk›l› oldu¤unu göstermektedir. Microcel PH101 ile Methocel K100LV içeren FM1 formülasyonu ve referans
®
ürün Isoptin -KKH`›n her ikisi Fick difüzyonuna uymayan sal›m göstermekte olup, fark faktörü (f1 = 9.4) ve
benzerlik faktörü (f2 = 56.8) de¤erlerine ba¤l› olarak benzer bulunmuﬂlard›r.
Sonuç: Uzat›lm›ﬂ sal›m yapan selüloz kökenli DT-ajan› ve düﬂük viskoziteye sahip HPMC polimeri içeren bir
matris tablet formülasyonu film kapl› tabletlere alternatif olarak haz›rlanabilmektedir.
Anahtar Sözcükler: Hidroksipropilmetilselüloz, Do¤rudan tabletleme ajanlar›, Matris tablet, ﬁiﬂme de¤eri,
Verapamil hidroklorür
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Introduction
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Materials and Methods
Materials

Verapamil HCl (VRP HCl) is a water-soluble phenylalkyl amine derivative, used widely in the treatment of
hypertension, angina pectoris and arrhythmias (1).

Verapamil HCl (Knoll AG, Ludwigshafen, Germany),
®
hydroxypropylmethylcellulose Methocel K100LV, K15M
and K100M with nominal viscosities of 98 mPa.s, 7382
mPa.s and 18,243 mPa.s respectively, Dow Chemical Co.,
®
Stade, Germany), microcrystalline cellulose (Microcel
PH101, Blanver Farmaquimica Ltda, Sao Paulo, Brazil),
α-lactose monohydrate 75%-cellulose powder 25%
®
mixture (Cellactose 80, Meggle GmbH, Wasserburg,
Germany), α-lactose monohydrate 96.5%-Kollidon 30
®
3.5% mixture (Ludipress LCE, BASF, Ludwigshafen,
Germany) and α-lactose monohydrate-amorph lactose
mixture (Pharmatose® DCL11, DMV International,
Veghel, The Netherlands), Isoptin®-KKH film coated
tablets (Knoll AG, Batch number: 156/96) were used. All
other chemicals used were analytical grade.

Various types of oral extended-release (ER) dosage
forms are currently in use, with coated beads, osmotic
pumps and matrix tablets being some of the important
classes (2). Among these classes, matrix tablets composed
of drug and the release-retarding material (polymer)
offer the simplest approach to designing an ER system.
Hydrophilic polymers like HPMCs are commonly used in
these systems as release-retarding materials (3). Several
formulation variables such as HPMC concentration and
viscosity grade, dosage size, excipient type and ratio have
been used to modulate drug release from HPMC-based
matrix tablets. According to different characteristics of
the polymers and excipients used, these drug delivery
systems exhibit different release kinetics and swelling
behaviors. In these systems, drug release profiles are
strongly influenced by the viscosity of the gel layer that
forms on the tablet surface as a result of hydration of the
constituent polymer and by the solubility of the excipient,
which affects the formation of the gel layer and the
hydrosolubility of the drug as well (4-7).

Preparation of Tablets
Tablets were prepared by direct compression. The
respective preweighed powders (drug, polymer and DCagent) were blended using a spatula on a glass plate (the
composition of each formula is presented in Table 1).
Then the mixture was fed manually into the die of a
hydraulic press (Ayaﬂlı Üçler, Ankara, Turkey) equipped
with flat-faced punches of 8 mm diameter to produce
tablets. The compaction force was kept constant at 255
MPa for 10 s.

The goals of the present study were to assess the
effect of different DC-agents including lactose (a soluble
excipient) and cellulose derivatives (insoluble excipients)
on the release of a soluble drug VRP HCl from hydrophilic
matrix tablets containing different viscosity grade HPMCs
and to investigate the swelling behaviors of these matrix
tablets.

In vitro Drug Release Studies
Drug release studies were carried out according to the
method given for Delayed Release Articles in USP XXVII

Table 1. Composition of matrix tablets.
Content (mg)

FM1

FM2

FM3

FC1

FC2

FC3

FL1

FL2

FL3
120

VRP HCl

120

120

120

120

120

120

120

120

Microcel® PH101

120

120

120

-

-

-

-

-

-

FP1

FP2

FP3

120

120

120

-

-

-

Cellactose® 80

-

-

-

120

120

120

-

-

-

-

-

-

Ludipress® LCE

-

-

-

-

-

-

120

120

120

-

-

-

Pharmatose® DCL11

-

-

-

-

120

120

120

Methocel K100LV

40

-

40

-

-

Methocel K15M

-

40

-

40

-

Methocel K100M

-

-

-

40
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-

-

-

-

-

-

-

40

-

-

40

-

-

-

40

-

-

40

-

40

-

-

40

-

-

40

-
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by using the USP paddle (apparatus II) method with a
dissolution tester (Aymes D96D, ‹stanbul, Turkey) at 50
rpm. pH 1.2 0.1 N HCl was used for the first 2 h and pH
6.8 phosphate buffer was used for the following 6 h as
dissolution media. The amount of VRP HCl was
determined spectrophotometrically (UV-1601 Shimadzu
Spectrophotometer, Tokyo, Japan) at 278 nm. All the
experiments were performed in triplicate. SPSS 9.0 for
Windows was used for calculations.
Determination of Swelling Degree of Hydrated
Matrix Tablets

Results and Discussion
In vitro Release and Swelling Studies
In hydrophilic matrices the release of drug is
controlled by the rate of formation of a partially hydrated
gel layer formed on the tablet surface upon contact with
aqueous gastric media (10). In this study rapidly
hydrating Methocel K series were used to prevent the
probable dose dumping of highly soluble VRP HCl, and
the level of HPMC in the tablets was kept lower than the
manufacturers’ suggestion (20%-40%) (11) to
determine the effect of DC-agents on drug release.
Drug release profiles of the matrix tablets containing
different DC-agents with Methocel K100LV are presented
®
in Figure 1a. FP1 containing Pharmatose DCL11 (lactose
100%) showed the fastest and FM1 containing Microcel®
PH101 (MCC 100%) showed the slowest release of drug.
FL1 containing Ludipress® LCE (lactose 96%-Kollidon 30
3.5%) and FC1 containing Cellactose® 80 (lactose 75%cellulose powder 25%) gave release profiles nearer to
that of FP1. However, the release of drug was faster
from FL1 with respect to the FC1 formulation.
Being a soluble excipient, lactose increases the tablet
porosity and stimulates the water penetration into the
inner parts of the matrix, which results in a faster
diffusion of drug and erosion of polymer, causing a rapid
release of drug from the tablets (5,11). Thus the rapid
release of drug from FP1, FL1 and FC1 formulations

100

3

80

2.6

60

ht/ho

Drug Released %

The thickness of hydrated tablets was measured by an
electrical device modified from that developed by Fatt (8)
by Karatas and Baykara (9). The same conditions (volume
of fluid, temperature, hydrodynamic conditions etc.) of
release studies were obtained for swelling studies.
Initially dehydrated tablet thickness was measured by this
electrical device and recorded as h0. Then the tablet was
immersed in dissolution medium. At selected time
intervals (the same as those in the release studies), the
hydrated tablet was taken out of dissolution medium and
its thickness was measured and then it was again
immersed in dissolution medium. Each measuring was
completed in 20 s and recorded as ht. The swell change
of each tablet was calculated as the normalized thickness
(ht/h0) and plotted versus time. All the experiments were
performed in triplicate. SPSS 9.0 for Windows was used
for calculations.
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Figure 1a. Drug release profiles for different DC-agents with Methocel
K100LV.
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FL1

FP1

Figure 1b. Swelling profiles of matrix tablets for different DC-agents
with Methocel K100LV.
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could be explained by the lactose content of their DCagents. These data are in accordance with some other
studies (3-5,12-14).
On the other hand, MCC is an insoluble excipient and
has a swelling property that contributes to the
development of swelling of HPMC and the resistance of the
gel layer. It is reported that the highest level (<10%) of
MCC is most likely acting as a strong tablet binder to
decrease tablet porosity and thus slows the release rate of
drug from the tablet formulations (5,15). The MCC level
was 41.5% (w/w) for Microcel® PH101 containing tablets
in our study, and so the delay in drug release for FM1
could be attributed to the high MCC content of its DCagent (3,5,13,14). However, the overall release of drug
from FP1, FL1, FC1 and FM1 formulations was rapid due
to the low viscosity grade of Methocel K100LV (3,6).
Drug release profiles of the matrices containing
different DC-agents with Methocel K15M are presented
in Figure 2a. FP2 containing Pharmatose® DCL11 showed
the fastest and FM2 containing Microcel® PH101 showed
the slowest release of drug due to their lactose and MCC
content respectively (3,10,12). Drug release from FL2
was slower than expected. This could be attributed to the
Kollidon 30 content of Ludipress® LCE and it could be
inferred that incorporation of Kollidon 30 with high
viscosity HPMC contributes to the increase in viscosity
and resistance of the gel layer that forms on the tablet
surface thus slows the drug release. The drug release

Turk J Med Sci

profile of FC2 was between those of FP2 and FM2
formulations, as expected. The increase in viscosity grade
of HPMC from 98 mPa.s to 7382 mPa.s resulted in a
decrease in the release rate of drug from the
formulations (Figure 1a and 2a) (3,10).
Drug release profiles of the matrices containing
different DC-agents with Methocel K100M are shown in
Figure 3a. As shown in Figure 2a and Figure 3a, an
increase in the viscosity grade of HPMC from 7382 mPa.s
to 18,243 mPa.s showed no marked decrease in the
release rate of drug from the matrix tablets, which was
also observed by some other investigators (16,17). In
contrast, an unexpected increase in the release rate of
drug was observed for the FC3 formulation containing
®
Cellactose 80 (Figure 3a).
Among all the formulations the release profile of FM1
containing Microcel® PH101 and Methocel K100LV
showed closer values to the limits of VRP HCl ER Tablets
monograph in USP XXVII, which was similar with the
release of Isoptin®-KKH (Figure 4).
During the swelling process a general trend was
observed in all formulations, namely a similar rapid
swelling for the first 15 min (Figures 1b, 2b, 3b). As
shown in Figure 1b, FM1 showed a distinct increase in gel
layer thickness due to its high content of swellable MCC
after 15 min. The fastest erosion was observed for FP1,
which has the highest lactose content in this group of
formulations. The surface erosion rate of FL1 was slower

3
100
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2.2

1.8
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Figure 2a. Drug release profiles for different DC-agents with Methocel
K15M.
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Figure 2b. Swelling profiles of matrix tablets for different DC-agents
with Methocel K15M.
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Figure 3a. Drug release profiles for different DC-agents with Methocel
K100M.
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540

FC3

FL3
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Figure 3b. Swelling profiles of matrix tablets for different DC-agents
with Methocel K100M.

As shown in Figure 2b, the high viscosity grade HPMC
exhibited extensive swelling with all DC-agents and no
marked difference was found between the swelling
profiles of formulations in this group. FM2 and FC2
including cellulose derivatives gave higher swelling values
compared to FL2 and FP2 including lactose. It has been
reported that low viscosity grade HPMCs are more
erodible (18,19) and high viscosity grade HPMCs are
more swellable (12,20). These data are in accordance
with our results as shown in Figures 1b and 2b.

100

Drug Released %

270
Time (min)

T im e (m in )
FM 3

180

80
60
40
20
0
0

90

180

270

360

450

540

Time (min)

USP XXVII min

USP XXVII max

FM1

Isoptin-KKH

Figure 4. Dissolution profile of FM1 and pharmacopeial limits of VRP
HCl ER tablets in USP XXVII.

than that of FP1, which could be attributed to the
Kollidon 30 content of Ludipress® LCE, and it can be
concluded that Kollidon 30 affected the resistance of the
gel layer towards erosion because of its binding property.
FC1 containing lactose and cellulose powder together
gave swelling profiles between those of FM1 and FL1
formulations. A similarity was observed between the
release and swelling profiles of these formulations’ order
(Figure 1a and 1b).

Swelling profiles of matrix tablets containing different
DC-agents with Methocel K100M are presented in Figure
3b. FC3 containing Cellactose® 80 exhibited unexpectedly
the highest degrees of swelling. FP3 containing
®
Pharmatose DCL11 gave the expected swelling and
eroding profile. Despite the higher lactose content of FL3,
almost the same swelling profiles were observed with
FM3. This may be explained by the higher gel strength of
the high viscosity grade HPMC counteracting erosion of
the gel layer. However, the similarity between the
swelling profiles of FL3 and FM3 was not observed in
their drug release profiles (Figure 3a).
As a result, while cellulose contributed to the strength
of the gel layer that forms on the surface of matrix
tablets, lactose weakened the structure of this gel layer,
which caused an increase in drug diffusion and gel layers’
erosion, and so accelerated the release of drug from the
matrices.
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Kinetic Evaluation of Drug Release
Drug release mechanisms of the matrix tablets were
evaluated by using the Korsmeyer-Peppas semi-empirical
model (21). In this model, the value of n identifies the
release mechanism of drug. For the case of cylindrical
tablets, 0.45 ≤ n corresponds to a Fickian diffusion
mechanism, 0.45 < n ≤ 0.89 to non-Fickian transport, n
= 0.89 to Case II (relaxational) transport, and n > 0.89
to super Case II transport (22,23). The values of release
parameters n and k are inversely related. A higher value
of k may suggest burst drug release from the matrix.
The calculated exponents (n) (Table 2) indicate that
the n values of all formulations and Isoptin®-KKH are
within the limits of the non-Fickian transport mechanism
except FM2, FM3 and FP3 formulations. However,
published data for cylindrical matrices containing HPMC
polymers showed that typical values of n were
approximately 0.6 (24), which is consistent with most of
our data (Table 2). As mentioned above, the higher k
value of FP1 was proved by rapid drug release from this
formulation (Table 2, Figure 1a).
Calculation of the approximate contribution of the
diffusional and relaxational mechanisms during the nonFickian release process was carried out by fitting the data to
the heuristic model proposed by Hopfenberg (25) and adapted
to pharmaceutical problems by Peppas and Sahlin (26).

Turk J Med Sci

In this model, drug release from swellable matrices is
described as a result of 2 transport mechanisms, i.e.
diffusion across the gel layer (F) and relaxation of the
polymeric chains (R). From fitting of the data to this
equation the ratio of relaxational (R) and Fickian (F)
contributions can be calculated by
R/F = k2 / k1 t

m

(Eqn)

The release data of formulations were analyzed
according to this equation. The R/F value of Isoptin®-KKH
was not calculated because of its being a coated film
tablet. The ratio of relaxational to diffusional
contributions vs. fraction released of drug are presented
in Figure 5. As shown in this figure, the contributions of
the 2 mechanisms for the fractional release of drug seem
to be almost equal for FC1, FC2, FM1 and FC3
formulations, corresponding to the non-Fickian transport
mechanism. For the other formulations (FL3, FL2, FP2)
the Fickian diffusion mechanism seems to be more
effective on drug release as evident from their values of
n (Table 2). Since a rapid release of drug occurred for
FL1 and FP1 formulations (Figure 1a) (probably caused
by a faster erosion rate of these formulations, Figure 1b),
these formulations did not exhibit the R/F profiles as
expected from their values of n. Lower n values of FM2
and FM3 formulations could be attributed to these
formulations’ extremely slow drug release rate after the
first 2 h (Figures 2a and 3a).

Table 2. Diffusion exponent (n) and kinetic constant (k) values of
formulations and Isoptin®-KKH.

0.8
0.7

Formulation
Code

Kinetic constant
k x 10-2 (m-n)

Diffusion exponent
n ± SD

FM1

1.66

0.635 ± 0.032

FM2

4.32

0.383 ± 0.021

FM3

4.27

0.375 ± 0.023

0.3

FC1

2.88

0.650 ± 0.037

0.2

FC2

2.11

0.589 ± 0.016

0.1

FC3

2.09

0.596 ± 0.024

FL1

1.82

0.858 ± 0.036

FL2

2.45

0.525 ± 0.020

FL3

2.04

0.541 ± 0.009

FP1

6.92

0.626 ± 0.051

FP2

3.63

0.517 ± 0.022

FP3

5.25

0.416 ± 0.016

Isoptin®-KKH.

0.01

0.689 ± 0.019

0.6
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Figure 5. Ratio of relaxational and diffusional contributions to overall
release vs. fractional VRP HCl release from matrix tablets.
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Among the formulations that fitted the non-Fickian
transport mechanism, FC1, FC2, FM1 and FC3 exhibited
diffusion and swelling controlled mechanisms at almost
equal ratios according to their R/F profiles, and the others
showed that drug release is mainly diffusive and deviated
from linearity. When DC-agents were evaluated from this
point of view, Cellactose® 80 showed an equal
contribution of diffusion and swelling with 3 types of
HPMCs, thus giving more linear results.
Dissolution profiles of FM1 and Isoptin®-KKH were
compared by f1-difference and f2-similarity factors. The

June 2006

values of 0-15 for f1 and the values of 50-100 for f2 are
acceptable (27). f1=9.4 and f2=56.8 values showed the
similarity of the release profiles of FM1 and Isoptin®-KKH.

Conclusion
An ER tablet formulation in agreement with USP
pharmacopeial requirements can be prepared by direct
compression as a matrix tablet using a microcrystalline
cellulose based DC-agent and a low viscosity grade HPMC
polymer as an alternative to film coated VRP HCl tablets.
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